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Abstract We report the first evidence that synthetic human C-
type natriuretic peptide-22 and the OaC-type natriuretic peptide-
39(18^39), a 22 amino acid fragment of the OaC-type natriuretic
peptide-39 from platypus venom, can function directly by
forming a novel voltage-gated weakly cation-selective channel
in negatively charged artificial lipid bilayer membranes. The
channel activity is characterized by a tendency for inactivation at
negative voltages, e.g. 360 and 370 mV, whereas at positive
voltages the channel is fully open. The channel has a maximal
cord conductance of 546 þ 23 pS (n = 16) and shows weak
outward rectification. The sequence and the permeability ratios
were PK : P

Cs : P

Na : P

choline 1:0.88:0.76:0.13, respectively.
The addition of 50 mM TEAcis (a blocker of outwardly
rectifying K channels), 20 mM Cscis (a blocker of inwardly
rectifying K channels) or 0.5 mM glibenclamidecis (a blocker of
ATP-sensitive K channels) to the cis chamber did not affect the
conductance or the kinetics of the OaC-type natriuretic peptide-
39(18^39)-formed channels (n = 2^5). It is concluded that the
weak cation selectivity, large conductance and high open
probability as well as their voltage dependency are consistent
with the ability of these peptides to cause that loss of
compartmentation of the membrane, which is a characteristic
feature of adverse conditions that cause C-type natriuretic
peptide-related pathologies.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
C-type natriuretic peptide (CNP), atrial natriuretic peptide
(ANP) and brain natriuretic peptide (BNP) form an important
family of peptides which exhibit potent natriuretic, diuretic,
hypotensive and vaso-relaxant properties [1^8]. C-type natriu-
retic peptides are distributed widely in the mammalian central
nervous system, the brain, endothelial cells, the lower part of
the gastro-intestinal tract and the kidney [2,3,9]. The physio-
logical function of CNP is not known. However, there is
evidence which suggests that C-type natriuretic peptides
have a pathologic role in cytokine-associated disorders, septic
shock and renal failure [10^12]. In particular, the role of CNP
as a potentially potent toxin is highlighted by the fact that
CNP from platypus venom was shown to be associated with
sustained tonic relaxation of the rat uterus in vitro, an e¡ect
mimicked by synthetic CNP [8,11]. The molecular mechanisms
underlying the action of these peptides are not well known. It
is thought that they act principally via the ANPB receptor,
particulate guanylate cyclase-B [6^13], leading to an increase
in the level of cGMP [14] which regulates ion transport path-
ways [15^18]. This in turn results in the inhibition of muscle
contraction leading to vasodilation and modi¢cation of £uid
and electrolyte homeostasis in salt secreting cells [2,8,11,19].
The aims of this study are to examine the ability of synthetic
human CNP-22 and the OaCNP-39(18^39) to form ion chan-
nels in arti¢cial bilayers and to characterize the type, conduct-
ance and kinetic properties of these channels. The data ob-
tained in this study indicate that synthetic human CNP-22
and the OaCNP-39(18^39) may exert their e¡ects by forming
ion channels.
2. Materials and methods
2.1. Synthesis of CNP
CNP-22, 1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22
(Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-
Met-Ser-Gly-Leu-Gly-Cys) and OaCNP-39(18^39), 1-2-3-4-5-6-7-8-
9-10-11-12-13-14-15-16-17-18-19-20-21-22 (Gly-Leu-Ser-Lys-Gly-Cys-
Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Thr-Ser-Gly-Leu-Gly-Cys)
are routinely synthesized and their amino acid sequences determined
at the Center for Molecular Structure and Function at the ANU as
detailed previously [8,11].
2.2. Lipid bilayer technique
Bilayers were formed across a 150 Wm hole in the wall of a 1 ml
Delrin cup using a mixture of palmitoyl-oleoyl-phosphatidylethanol-
amine, palmitoyl-oleoyl-phosphatidylserine and palmitoyl-oleoyl-
phosphatidylcholine (5:3:2, by volume) [20,21], obtained in chloro-
form from Avanti Polar Lipids (Alabaster, AL). The lipid mixture
was dried under a stream of N2 and redissolved in n-decane at a ¢nal
concentration of 50 mg/ml. Synthetic CNP-22 or OaCNP-39(18^39),
which each have three charged amino acids with a net charge of +2,
were then incorporated into the negatively charged lipid bilayer by
addition to the cis chamber at a ¢nal peptide concentration of 0.1^1
Wg/ml. The side of the bilayer to which the peptide was added is
de¢ned as cis, and the other side as trans. Ion channels were also
recorded from a peptide:lipid mixture of 1:50. Unless it is otherwise
stated, the initial experimental solution for incorporating synthetic
CNP-22 or OaCNP-39(18^39) into the bilayers contained KCl (250
mM cis and 50 mM trans) plus 1 mM CaCl2 and 10 mM HEPES
bu¡er (adjusted with 4.8 mM KOH to pH 7.4). Potassium channel
blockers (Sigma) stock solutions are added to the cis or trans cham-
bers. The experiments are conducted at 20^25‡C.
2.3. Ion channel recording
The pClamp6 program (Axon Instruments) is used for voltage com-
mand and acquisition of ionic current families with an Axopatch 200
ampli¢er (Axon Instruments). The current is monitored with an os-
cilloscope and the data are stored on a computer. The cis and trans
chambers are connected to the ampli¢er head stage by Ag/AgCl elec-
trodes in agar, salt bridges containing solutions are present in each
chamber. Voltages and currents are expressed relative to the trans
chamber. Data are ¢ltered at 1 kHz (4-pole Bessel, 33 dB) and digi-
tized via a TL-1 DMA interface (Axon Instruments) at 2 kHz.
2.4. Data analysis
Data are obtained only from bilayers having a speci¢c capacitance
of s 0.42 WF/cm2 and which contain one active K channel [21].
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Kinetic analysis was conducted only for optimal bilayers that con-
tained a single active channel. Single channel activity is analyzed for
overall characteristics using the program Channel 2 [21]. It is used to
obtain the open probability, Po, i.e. the fraction of time that the
channel is open. The threshold level for the detection of single channel
events is set at 50% of the maximum current [22]. The reversal po-
tential (Vrev) was corrected for ionic mobility and liquid junction
potential [23] and the relative ion permeabilities were calculated ac-
cording to the equation [24]:
PX=PK  Ktrans3KcisexpzFVrev=RTg=XcisexpzFVrev=RT:

3. Results
We used pClamp6 software (Axon instruments) to com-
mand and acquire ionic currents through single CNP-22-
and OaCNP-39(18^39)-formed channels in lipid bilayer mem-
branes clamped at potentials between 370 and +80 mV. The
channel activity is characterized by a tendency for inactivation
at negative voltages, e.g. 360 and 370 mV. The constructed
current-voltage relationships of the single CNP-22-formed ion
channels currents (Fig. 1B), which show weak outward recti-
¢cation, were ¢tted with two exponentials. The current’s re-
versal potential (Vrev) of 323.2 þ 4.7 mV (n = 3) was closer to
the EK (335 mV) than ECl3 (+35 mV), indicating that the
current was mainly due to the movement of K, though some
Cl3 also passed through the channel.
The time course of the current transitions reveals inactiva-
tion of the channel at voltages more negative than 340 mV
(Fig. 1C). At 370 mV, 12 out of 16 episodes showed channel
inactivation after 1.3 þ 0.4 s (n = 12). At 360 mV these values
were observed in seven out of 16 episodes and the channel
inactivated after 1.7 þ 0.4 s (n = 7). The voltage dependence of
the inactivation was determined in bilayer membranes con-
taining multiple active CNP-22 (b) and OaCNP-39(18^39)
(F) channels by plotting the ratio (Iss/Iin) of the current at
the end of the voltage step to the initial current activated
immediately after the voltage step (Fig. 1D). The data indicate
that 50% reduction in the inactivation ratio Iss/Iin of CNP-22-
and OaCNP-39(18^39)-formed channels occurs at 356.7 þ 5.4
mV (n = 1^3).
The CNP-22- and OaCNP-22-formed channels were stable
and irreversibly associated with the lipid bilayers that main-
tained their speci¢c capacitance of s 0.42 WF/cm2. These ¢nd-
ings indicate that it is unlikely that these formed channels
were due to peptide-induced structural disturbances of the
bilayer. Furthermore, CNP-22 and OaCNP-22, when inacti-
vated by boiling the peptides in 250 mM KCl, failed to form
channels in the lipid bilayer at comparable concentrations and
for similar durations, indicating that certain natural features
of the bioactive peptide are needed for channel formation. In
order to ascertain that this was not due to a low probability of
peptide incorporation into the lipid bilayer, liposomes [25]
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Fig. 1. Voltage dependence of CNP-22-formed single cation channels. A: Representative current traces illustrating single channel activity re-
corded from a voltage-clamped optimal bilayer, i.e. speci¢c bilayer capacitance s 42 WF/cm2 in asymmetrical KCl (250 mM/50 mM, cis/trans)
plus 1 mM CaCl2 and 10 mM HEPES (pH 7.4, adjusted with Tris). Following the convention, the upward de£ections denote activation of the
outward cation current, i.e. potassium ions moving from the cis chamber to the trans chamber. For a better display the data are ¢ltered at
1 kHz, digitized at 2 kHz and reduced by a factor 10 and the traces are o¡set by 10 pA. B: The current-voltage relationship exhibited a weak
outward recti¢cation, which is characteristically ¢tted with two exponentials. C: Current traces illustrating inactivation of the single channel ac-
tivity at negative voltages. The rest as in A. D: The voltage dependence of the ratio, Iss/Iin, the current at the end of the voltage step to the in-
itial current activated immediately after the voltage steps. Symbols are for two bilayers, each containing three active CNP-22 (b) and OaCNP-
39(18^39) (F) channels. The solid lines are drawn to a third order polynominal ¢t of the data for channels.
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were used to detect the incorporation of the peptide into the
bilayer, by monitoring the speci¢c capacitance of the lipid
bilayer. Although the liposomes were incorporated into the
bilayer as indicated by the increase in the speci¢c capacitance,
no channel activities were observed for either CNP-22 or
OaCNP-22 (n = 4 and 5), respectively.
We further determined the cation selectivity of the channel
in ion substitution experiments. The 250 mM KCl in the cis
chamber was totally replaced by 250 mM choline-Cl, NaCl, or
CsCl and families of current traces were obtained at voltages
between 370 and +80 mV. During these replacements the
channel protein remained irreversibly associated with the lipid
bilayer. The constructed current-voltage relationships from
these current families revealed reduction in the current ampli-
tude and only small shifts in Vrev, indicating a poor mono-
valent cationic selectivity (Fig. 2A). The sequence and
the mean permeability ratios for three channels (one
CNP-22 and two OaCNP-39(18^39)) were found to be
PK : P

Cs : P

Na : P

choline 1:0.88:0.76:0.13, respectively.
We also examined the pharmacology of the channel by
determining its sensitivity to K channel antagonists. We
found that this cation channel is neither a TEA-sensitive, a
Cs-sensitive nor an ATP-sensitive K channel, since neither
the addition of 50 mM TEAcis (a blocker of the outwardly
rectifying K channel), 20 mM Cscis (a blocker of the in-
wardly rectifying K channel) nor 0.5 mM glibenclamidecis (a
blocker of the ATP-sensitive K channel) to the cis chamber
a¡ect the time course or the kinetics of the OaCNP-39(18^39)-
formed channels. Neither the weak outward recti¢cation of
the current-voltage relations nor the Vrev were a¡ected by
these K channel blockers (Fig. 2B).
We obtained the kinetic parameters of the CNP-22 and
OaCNP-39(18^39)-formed channels by analyzing channel ac-
tivity recorded at positive and negative voltages (Fig. 3). At
positive voltages between 0 and +80 mV, the probability of
the channel being open, Po, was virtually constant and had a
value of 1. At negative voltages between 370 and 310 mV,
the Po had a bell-shaped curve with a peak at 360 mV. The
channel frequency, Fo, decreased from 14.96 events/s at 370
mV to 0.8 events/s at +80 mV. The mean open time, To,
increased from 65 ms at 370 mV to 201 ms at 350 mV
and to 335 ms at 330 mV. In contrast, the mean closed
time, Tc, decreased exponentially from 16.4 ms at 370 mV
to 0.5 ms at 320 mV.
The decline in the probability of the channel being open at
voltages more negative than 370 mV is due to the inactiva-
tion of the channel (n = 23 families of current traces from
three channels). Note that in all current traces the CNP-22-
or OaCNP-39(18^39)-formed channels became inactivated at
negative voltages. For example, in Fig. 1C, the bilayer which
contained at least three channels shows such a channel inac-
tivation at negative voltages. To con¢rm that the decline in
the open probability of the channel at negative voltages is due
to channel inactivation, we constructed the ensemble average
of the currents of 20 episodes at 350, 360, 370 and 380 mV
(Fig. 4). The data show that the channel was open at 350 and
360 mV. On the other hand, at 370 and 380 mV it tended to
inactivate and the inactivation of the currents could be de-
scribed by two exponentials, where d1 and d2 are, respectively,
537 ms and 952 ms at 370 mV and 719 and 2937 ms at 380
mV. These ¢ndings indicate that the decline in the open prob-
ability at Vm is more negative than 370 mV, because of
channel inactivation.
4. Discussion
The channel activity reported here was seen only when pep-
tides were added to the cis chamber, and thus points to their
interaction with the lipid bilayers. The data in Figs. 1^4 in-
dicate that the conductance and kinetic properties of the cat-
ion channel were not a¡ected by substitution of Met (CNP-
22) to Thr (OaCNP-39(18^39)) at the amino acid position 17
(see Section 2) (n = 32). Similarly, the respective compositions
of the phospholipid mixture, 5:3:2 PE:PS:PC and 5:5 PE:PS,
had no e¡ects on the channel activity (n = 5). The fact that
OaCNP-39(18^39) forms channels in lipid bilayer membranes
at pH 7.4 and voltages between 380 and +80 mV suggests
that voltage and acidic conditions are not required for the
peptide domains to dock onto and interact with the bilayer
in order to form ion channels, as suggested for colicin E1 [26]
and Bcl-2-formed channels [27]. These ¢ndings, taken together
with the biophysical properties of the 546 pS channel, point to
a channel that is di¡erent from the previously reported pep-
tide- or toxin-formed voltage-dependent cation channels such
as the staphylococcal N-toxin-induced 70^100 and 450 pS
channels [28], the tetanus toxin-induced 89 pS channel (500
mM KCl) [29] and the Clostridium botulinum C2-II toxin-in-
duced 55 pS channel (100 mM KCl) [30]. This weakly cation-
selective channel may represent a new member of the class of
amyloid forming peptides (Table 1) which form channels and
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Fig. 2. Ion selectivity of the OaCNP-39(18^39)-formed channel. A:
Current-voltage relationships for di¡erent cations: (b) K, (F) Na,
(R) Cs, and (S) choline. B: E¡ects of K channel blockers.
Current voltage relationships (b) control, (F) 20 mM TEAcis, (R)
20 mM Cscis, and (S) 0.5 mM glibenclamidecis.
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it may be responsible for disease pathology in various amy-
loidoses. This class of peptides, whose channel forming char-
acteristics are shown in Table 1, includes: ALP-formed Ca2
channel [25,31,32], prion peptide PrP (106^126)-formed volt-
age-independent 20^60 pS (in 100 mM NaCl) non-selective
(PNa/PCl V2.5) ion channel [33] and amylin-formed volt-
age-dependent 7.5 pS (in 10 mM KCl) non-selective ion-per-
meable channel [34]. Although natriuretic peptides di¡er from
amyloids in their amino acid sequence, charged domains and
the disul¢de-linked loop (Table 1), there appear to be some
¢ndings to suggest that natriuretic peptides may be related to
amyloids. These ¢ndings include: (a) common motifs, which
make both types of peptides substrates to the insulin-degrad-
ing enzyme [35] and the GLG motif : (b) atrial natriuretic
peptide is a precursor or a major subunit of amyloid
[36,37] : (c) natriuretic peptides and amyloids elevate cGMP
via interaction with guanylate cyclase receptors [38^40]: (d)
natriuretic peptides are occurring together with amyloid in
amyloid deposits [41]. The prion peptide PrP (106^126) also
does not have a disul¢de-linked loop, the GlG motif or the
charges in the center of its amino acid sequence.
The structure of the natriuretic peptides (ANP, BNP and
CNP) incorporates a 17 residue intra-molecular disul¢de loop
(between residues 6 and 22) with amino acid sequences which
are identical in ANP and BNP, whilst CNP is the same, ex-
cept for two residues [1^4,9]. In contrast to ANP and BNP,
which possess C- and N-terminal sequence extensions beyond
this loop, CNP extends only N-terminally [6,8,11]. Therefore,
it is not unreasonable to suggest that ANP and BNP may also
form ion channels.
This study provides evidence showing that, in addition to
CNP22-activated guanylate cyclase [14] which induces cGMP
release that interacts with K channels [15,16], Cl3 channels
sodium absorption in murine airway epithelium [17,18] and
chloride secretion in the rectal gland of Squalus acanthias
[43], CNP-22 may also function, by virtue of its ability to
form ion channels, as an e⁄cient ion transport pathway for
signal transduction. The concentrations of CNP-22 or
FEBS 21553 19-2-99
Fig. 3. Voltage dependence of the CNP-22- (b) and OaCNP-39(18^39)- (F) formed channel kinetic parameters. A: Open probability (Po).
B: Frequency Fo. C: Mean open time To. D: Mean closed time Tc. The solid lines are drawn to a third order polynomial ¢t in A, B and D
and to a second order polynomial ¢t in C.
Fig. 4. The mean (n = 21) ensemble current through the OaCNP-
39(18^39)-formed channel clamped to 1 =350, 2 =360, 3 =370 and
4 =380 mV from a holding potential of 0 mV. After the initial
large transient capacitive current, the channels are activated and re-
main open in 1 (see also Fig. 1C) and are inactivated in 2, 3 and 4.
The solid lines are drawn to a second order polynomial ¢t in 3 and
4. For a better display, the ensemble current traces are o¡set by 10
pA.
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OaCNP-22 used to obtain channel activity are comparable to
concentrations of several cytotoxic channel forming peptides
(see [34]). In vivo the CNP-22-formed weakly cation-selective
546 pS channel with high open probability is expected to
induce changes in Vm, second messenger systems (e.g.
cGMP and Ca2 homeostasis) and electrolyte homeostasis.
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